Bolt Biotherapeutics, Inc. (BOLT)
6.00
+0.09
(+1.52%)
USD |
NASDAQ |
Nov 13, 10:38
Bolt Biotherapeutics Free Cash Flow (Quarterly) : -6.54M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.54M |
| March 31, 2026 | -8.023M |
| December 31, 2025 | -7.156M |
| September 30, 2025 | -9.804M |
| June 30, 2025 | -9.597M |
| March 31, 2025 | -13.36M |
| December 31, 2024 | -14.43M |
| September 30, 2024 | -14.01M |
| June 30, 2024 | -16.14M |
| March 31, 2024 | -16.75M |
| December 31, 2023 | -14.27M |
| September 30, 2023 | -16.91M |
| June 30, 2023 | -15.14M |
| March 31, 2023 | -23.40M |
| Date | Value |
|---|---|
| December 31, 2022 | -18.14M |
| September 30, 2022 | -14.19M |
| June 30, 2022 | -21.22M |
| March 31, 2022 | -24.92M |
| December 31, 2021 | -18.36M |
| September 30, 2021 | -19.74M |
| June 30, 2021 | -4.689M |
| March 31, 2021 | -16.62M |
| December 31, 2020 | -13.79M |
| September 30, 2020 | -13.67M |
| June 30, 2020 | -13.10M |
| March 31, 2020 | -10.01M |
| December 31, 2019 | -6.329M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Caribou Biosciences, Inc. | -22.54M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |
| Sarepta Therapeutics, Inc. | 53.83M |